Scott Weiss, senior director of product management, IDBS talks about the Internet of Things (IoT) and externalised research and development (R&D) in life sciences
Johnson Matthey recently expanded its Cambridge facility to add process development and small-scale manufacturing capabilities. Brian Fairley and Antonio Zanotti-Gerosa explain how this will benefit pharmaceutical manufacturing
So the pharma landscape continues to evolve. It’s interesting to witness the changes taking place, many of them using technology to improve the way medicine and drugs are administered, monitored and prescribed
Philippe Villain-Guillot, Nosopharm, highlights how the company is countering multi-drug antimicrobial resistance and explains how partnering with the company is an opportunity for the pharmaceutical businesses to grow their antibacterial pipeline
Ashleigh Paparella, post-graduate researcher in the structural biology and drug design lab, at the University of Adelaide, talks about the challenges that antimicrobial resistance poses and possible ways around it
Over recent years the UK, in particular the North West, has been leading the life sciences charge. Lu Rahman highlights how the region is looking to become a global leader for the sector
As always innovation has been a key element in this year’s pharmaceutical sector. Lu Rahman handpicks her favourite stories showing the breakthroughs that have taken place over the last 12 months
The solution to Anti-Microbial Resistance (AMR) is widely thought to lie in the development of new antibiotics and diagnostic tests however Helen Lambert disagrees
The European Federation of Pharmaceutical Industries and Associations discusses the importance of its Partners in Research initiative to boost research in healthcare
Without competent researchers, innovation processes in European medicines development will not be sustainable, say Klaus Wassermann and Christa Janko, EMTRAIN
